The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.

Jacques Fantini (1) , Christian Devaux (2, 3, 4) , Nouara Yahi (1) , Roger Frutos (5, 6)

1 UNIS - Inserm U1072 - Unité de Neurobiologie des canaux Ioniques et de la Synapse
2 MEPHI - Microbes évolution phylogénie et infections
3 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
4 CNRS - Centre National de la Recherche Scientifique
5 UMR INTERTRYP - Interactions hôtes-vecteurs-parasites-environnement dans les maladies tropicales négligées dues aux trypanosomatides
6 Cirad-BIOS - Département Systèmes Biologiques

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology

Jacques Fantini, Christian Devaux, Nouara Yahi, Roger Frutos. The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.. Journal of Infection, 2022, 84 (5), pp.e53-e54. ⟨10.1016/j.jinf.2022.03.001⟩. ⟨hal-03818205⟩